Table 2

Associations between lung function measures and allergic disease outcomes with childhood home environment (inner city reference group)

Inner city, % (n)Village/town/suburb, % (n)Farm, % (n)Village/town/suburb,
OR (95% CI) or mean difference (SD)
Farm,
OR (95% CI I) or mean difference (SD)
BHR18 (306)16 (625)12 (78)
 +BHR − atopy1.05 (0.81 to 1.36)0.92 (0.61 to 1.39)
 −BHR + atopy0.82 (0.69 to 0.96)0.46 (0.34 to 0.61)
 +BHR + atopy0.88 (0.69 to 1.11)0.54 (0.35 to 0.83)
Mean FEV1/FVC (SD)*80.2 (6.8)80.0 (6.7)80.6 (6.8)−0.06 (−0.41 to 0.29), p=0.7460.60 (0.04 to 1.16), p=0.036
Any atopic sensitisation38 (771)31 (1564)18 (143)0.83 (0.73 to 0.94)0.46 (0.37 to 0.58)
 Nasal symptoms36 (950)32 (1992)25 (230)
 +Nasal symptoms
 −Atopy
1.04 (0.87 to 1.24)0.96 (0.73 to 1.26)
 −Nasal symptoms
 +Atopy
0.76 (0.64 to 0.91)0.51 (0.37 to 0.69)
 +Nasal symptoms
 +Atopy
0.90 (0.77 to 1.05)0.43 (0.32 to 0.57)
Current asthma6.1 (168)5.5 (361)4.4 (41)
 +Current asthma
 −Atopy
1.08 (0.72 to 1.61)1.09 (0.60 to 1.99)
 −Current asthma
 +Atopy
0.82 (0.72 to 0.93)0.47 (0.37 to 0.59)
 +Current asthma
 +Atopy
0.92 (0.70 to 1.21)0.47 (0.28 to 0.81)
  • Statistically significant associations are in bold.

  • Adjustment for age, sex, study centre, smoking and family history of allergic disease.

  • *Additional adjustment: height2 and weight.

  • BHR, bronchial hyper-responsiveness.